The autologous stem cell and non-stem cell therapies market is set to grow significantly, with estimates suggesting a rise to $22.2 billion by 2029 from $5.5 billion in 2024, indicating a CAGR of 32.3%. This growth is fueled by regulatory approvals for innovative therapies like autologous CAR T-cell and Tumor Infiltrating Lymphocyte (TIL) therapies, along with increased investments in research...

The global contrast medial injectors market is expected to grow from USD 1.6 billion in 2024 to USD 2.3 billion by 2029, at a CAGR of 8.0%. Key drivers include the rising incidence of cancer and cardiovascular diseases, especially among the aging population, and advancements in injector technology that enhance diagnostic accuracy and early detection. Increased disposable incomes and expanding...

The report "Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application(Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028", is projected to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6%...

The fusion biopsy market has emerged as a pivotal segment within the broader healthcare and diagnostic imaging landscape. Fusion biopsy combines advanced imaging techniques, such as magnetic resonance imaging (MRI) and ultrasound, to provide enhanced accuracy in diagnosing various conditions, particularly prostate cancer. This innovative approach addresses the limitations of traditional biopsy...

The mRNA synthesis and manufacturing market is projected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024. This market is projected to grow at a CAGR of 3.4% over the forecast period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA...

The mRNA synthesis and manufacturing market is projected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024. This market is projected to grow at a CAGR of 3.4% over the forecast period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA...

The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024  to 2030. The major factors driving the growth of the AI in precision medicine market include rapidly increasing need for more customized treatments, improvement in genomics and multi-omics technologies, and a drive to accelerate drug...

The size of global hollow fiber filtration market in terms of revenue was estimated to be worth $303 million in 2021 and is poised to reach $597 million by 2026, growing at a CAGR of 14.5% from 2021 to 2026.  The growth of the global market is driven by factors such as the rising preference for continuous manufacturing, the increasing use of single-use technologies, and the rising...

The hearing aids industry is likely to experience significant growth in the near future. This growth is driven by the increasing demand for hearing aids, driven by the aging population and the need to address hearing loss, as well as advances in technology that are making hearing aids more accessible and effective. There are several trends that are likely to shape the hearing aids industry in...

The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024  to 2030. The major factors driving the growth of the AI in precision medicine market include rapidly increasing need for more customized treatments, improvement in genomics and multi-omics technologies, and a drive to accelerate drug...